UBS Group
BIOTW icon

UBS Group’s Instinct Bio Technical Company Holdings Warrants BIOTW Stock Holding History

UBS Group’s Portfolio BIOTW Stock Details BIOTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$10 Buy
+699
New +$14 ﹤0.01% 11077

Other funds holding BIOTW

Context Capital Management
Context Capital Management Lajolla, California $4.89B AUM 1.86% 1-Year Est. Return
StoneX Group
StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return
Wolverine Asset Management
Wolverine Asset Management Chicago, Illinois $14.9B AUM 3.61% 1-Year Est. Return
Periscope Capital
Periscope Capital Toronto, Ontario, Canada $990M AUM 4.73% 1-Year Est. Return
Morton Capital Management
Morton Capital Management Calabasas, California $828M AUM 13.29% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Landscape Capital Management
Landscape Capital Management Englewood, New Jersey $1.34B AUM 18.69% 1-Year Est. Return

UBS Group's BIOTW Position: Q3 2026 in Review

UBS Group opened a new position in Instinct Bio Technical Company Holdings Warrants (BIOTW) in Q3 2026: 699 shares worth $10. The stake represents ﹤0.01% of the portfolio and ranks #11077 among its holdings.

8 funds tracked by Wall St. Rank hold BIOTW as of Q3 2026.

  • UBS Group held 699 shares of Instinct Bio Technical Company Holdings Warrants worth $10 as of Q3 2026.
  • Instinct Bio Technical Company Holdings Warrants was a new UBS Group position in Q3 2026.
  • Instinct Bio Technical Company Holdings Warrants made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #11077 holding.
  • 8 funds tracked by Wall St. Rank held Instinct Bio Technical Company Holdings Warrants as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.